Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2010 Apr 18;2(2):114–124. [Article in French] doi: 10.1016/S1877-1203(10)70014-8

Insuffisance Respiratoire Aiguë chez le patient immunodéprimé : Quelle approche diagnostique ?

L Camous 1, V Lemiale 1, D Schnell 1, S de Miranda 1, E Azoulay 1,⁎
PMCID: PMC7140285  PMID: 32288904

The content is available as a PDF (433.7 KB).

Références

  • 1.Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet. 2002;360:1131–1135. doi: 10.1016/S0140-6736(02)11199-8. [DOI] [PubMed] [Google Scholar]
  • 2.Linker C., Damon L., Ries C., Navarro W. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. J Clin Oncol. 2002;20:2464–2471. doi: 10.1200/JCO.2002.07.116. [DOI] [PubMed] [Google Scholar]
  • 3.Richardson P.G., Sonneveld P., Schuster M.W., Irwin D., Stadtmauer E.A., Facon T., Harousseau J.L., Ben-Yehuda D., Lonial S., Goldschmidt H., Reece D., San-Miguel J.F., Bladé J., Boccadoro M., Cavenagh J., Dalton W.S., Boral A.L., Esseltine D.L., Porter J.B., Schenkein D., Anderson K.C., Assessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med. 2005;352:2487–2498. doi: 10.1056/NEJMoa043445. [DOI] [PubMed] [Google Scholar]
  • 4.O’Brien S.G., Guilhot F., Larson R.A., Gathmann I., Baccarani M., Cervantes F., Cornelissen J.J., Fischer T., Hochhaus A., Hughes T., Lechner K., Nielsen J.L., Rousselot P., Reiffers J., Saglio G., Shepherd J., Simonsson B., Gratwohl A., Goldman J.M., Kantarjian H., Taylor K., Verhoef G., Bolton A.E., Capdeville R., Druker B.J., IRIS Investigators Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronicphase chronic myeloid leukemia. N Engl J Med. 2003;348:994–1004. doi: 10.1056/NEJMoa022457. [DOI] [PubMed] [Google Scholar]
  • 5.Coiffier B., Lepage E., Briere J., Herbrecht R., Tilly H., Bouabdallah R., Morel P., Van Den Neste E., Salles G., Gaulard P., Reyes F., Lederlin P., Gisselbrecht C. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235–242. doi: 10.1056/NEJMoa011795. [DOI] [PubMed] [Google Scholar]
  • 6.Bergh J., Wiklund T., Erikstein B., Lidbrink E., Lindman H., Malmström P., Kellokumpu-Lehtinen P., Bengtsson N.O., Söderlund G., Anker G., Wist E., Ottosson S., Salminen E., Ljungman P., Holte H., Nilsson J., Blomqvist C., Wilking N. Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study. Lancet. 2000;356:1384–1391. doi: 10.1016/s0140-6736(00)02841-5. [DOI] [PubMed] [Google Scholar]
  • 7.Azoulay E., Recher C., Alberti C., Soufir L., Leleu G., Le Gall J.R., Fermand J.P., Schlemmer B. Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med. 1999;25:1395–1401. doi: 10.1007/s001340051087. [DOI] [PubMed] [Google Scholar]
  • 8.Kress J.P., Christenson J., Pohlman A.S., Linkin D.R., Hall J.B. Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med. 1999;160:1957–1961. doi: 10.1164/ajrccm.160.6.9812055. [DOI] [PubMed] [Google Scholar]
  • 9.Soares M., Fontes F., Dantas J., Gadelha D., Cariello P., Nardes F., Amorim C., Toscano L., Rocco J.R. Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study. Crit Care. 2004;8:R194–R203. doi: 10.1186/cc2870. Epub 2004 May 24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Azoulay E., Thiéry G., Chevret S., Moreau D., Darmon M., Bergeron A., Yang K., Meignin V., Ciroldi M., Le Gall J.R., Tazi A., Schlemmer B. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine. 2004;83:360–370. doi: 10.1097/01.md.0000145370.63676.fb. [DOI] [PubMed] [Google Scholar]
  • 11.Chaoui D., Legrand O., Roche N., Cornet M., Lefebvre A., Peffault de Latour R., Sanhes L., Huchon G., Marie J.P., Rabbat A. Incidence and prognostic value of respiratory events in acute leukemia. Leukemia. 2004;18:670–675. doi: 10.1038/sj.leu.2403270. [DOI] [PubMed] [Google Scholar]
  • 12.Azoulay E., Alberti C., Bornstain C., Leleu G., Moreau D., Recher C., Chevret S., Le Gall J.R., Brochard L., Schlemmer B. Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med. 2001;29:519–525. doi: 10.1097/00003246-200103000-00009. [DOI] [PubMed] [Google Scholar]
  • 13.Meert A.P., Close L., Hardy M., Berghmans T., Markiewicz E., Sculier J.P. Noninvasive ventilation: application to the cancer patient admitted in the intensive care unit. Support Care Cancer. 2003;11:56–59. doi: 10.1007/s00520-002-0373-0. [DOI] [PubMed] [Google Scholar]
  • 14.Rabbat A., Chaoui D., Montani D., Legrand O., Lefebvre A., Rio B., Roche N., Lorut C., Marie J.P., Huchon G. Prognosis of patients with acute myeloid leukaemia admitted to intensive care. Br J Haematol. 2005;129:350–357. doi: 10.1111/j.1365-2141.2005.05459.x. [DOI] [PubMed] [Google Scholar]
  • 15.Hilbert G., Gruson D., Vargas F., Valentino R., Gbikpi-Benissan G., Dupon M., Reiffers J., Cardinaud J.P. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med. 2001;344:481–487. doi: 10.1056/NEJM200102153440703. [DOI] [PubMed] [Google Scholar]
  • 16.Azoulay E., Schlemmer B. Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med. 2006;32:808–822. doi: 10.1007/s00134-006-0129-2. [DOI] [PubMed] [Google Scholar]
  • 17.Dunagan D.P., Baker A.M., Hurd D.D., Haponik E.F. Bronchoscopic evaluation of pulmonary infiltrates following bone marrow transplantation. Chest. 1997;111:135–141. doi: 10.1378/chest.111.1.135. [DOI] [PubMed] [Google Scholar]
  • 18.White P., Bonacum J.T., Miller C.B. Utility of fiberoptic bronchoscopy in bone marrow transplant patients. Bone Marrow Transplant. 1997;20:681–687. doi: 10.1038/sj.bmt.1700957. [DOI] [PubMed] [Google Scholar]
  • 19.Murray P.V., O’Brien M.E., Padhani A.R., Powles R., Cunningham D., Jeanes A., Ashley S. Use of first line bronchoalveolar lavage in the immunosuppressed oncology patient. Bone Marrow Transplant. 2001;27:967–971. doi: 10.1038/sj.bmt.1703020. [DOI] [PubMed] [Google Scholar]
  • 20.Stover D.E., Zaman M.B., Hajdu S.I., Lange M., Gold J., Armstrong D. Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Intern Med. 1984;101:1–7. doi: 10.7326/0003-4819-101-1-1. [DOI] [PubMed] [Google Scholar]
  • 21.Gruson D., Hilbert G., Portel L., Boiron J.M., Bebear C.M., Vargas F., Bebear C., Reiffers J., Gbikpi-Benissan G., Cardinaud J.P. Severe respiratory failure requiring ICU admission in bone marrow transplant recipients. Eur Respir J. 1999;13:883–887. doi: 10.1034/j.1399-3003.1999.13d31.x. [DOI] [PubMed] [Google Scholar]
  • 22.Gruson D., Hilbert G., Portel L., Boiron J.M., Bebear C.M., Vargas F., Bebear C., Reiffers J., Gbikpi-Benissan G., Cardinaud J.P. Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltrates. Crit Care Med. 2000;28:2224–2230. doi: 10.1097/00003246-200007000-00007. [DOI] [PubMed] [Google Scholar]
  • 23.Azoulay E., Fieux F., Moreau D., Thiery G., Rousselot P., Parrot A., Le Gall J.R., Dombret H., Schlemmer B. Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med. 2003;167:1329–1333. doi: 10.1164/rccm.200206-554OC. [DOI] [PubMed] [Google Scholar]
  • 24.Cordonnier C., Escudier E., Nicolas J.C., Fleury J., Deforges L., Ingrand D., Bricout F., Bernaudin J.F. Evaluation of three assays on alveolar lavage fluid in the diagnosis of cytomegalovirus pneumonitis after bone marrow transplantation. J Infect Dis. 1987;155:495–500. doi: 10.1093/infdis/155.3.495. [DOI] [PubMed] [Google Scholar]
  • 25.Agustí C., Ramirez J., Picado C., Xaubet A., Carreras E., Ballester E., Torres A., Battochia C., Rodriguez-Roisin R. Diffuse alveolar hemorrhage in allogeneic bone marrow transplantation. A postmortem study. Am J Respir Crit Care Med. 1995;151:1006–1010. doi: 10.1164/ajrccm/151.4.1006. [DOI] [PubMed] [Google Scholar]
  • 26.Afessa B., Tefferi A., Litzow M.R., Krowka M.J., Wylam M.E., Peters S.G. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med. 2002;166:641–645. doi: 10.1164/rccm.200112-141cc. [DOI] [PubMed] [Google Scholar]
  • 27.Trof R.J., Beishuizen A., Debets-Ossenkopp Y.J., Girbes A.R., Groeneveld A.B. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med. 2007;33:1694–1703. doi: 10.1007/s00134-007-0791-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Castagnola E., Bagnasco F., Faraci M., Caviglia I., Caruso S., Cappelli B., Moroni C., Morreale G., Timitilli A., Tripodi G., Lanino E., Haupt R. Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience. Bone Marrow Transplant. 2008;41:339–347. doi: 10.1038/sj.bmt.1705921. [DOI] [PubMed] [Google Scholar]
  • 29.Patterson T.F., Kirkpatrick W.R., White M., Hiemenz J.W., Wingard J.R., Dupont B., Rinaldi M.G., Stevens D.A., Graybill J.R. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine. 2000;79:250–260. doi: 10.1097/00005792-200007000-00006. [DOI] [PubMed] [Google Scholar]
  • 30.Dettenkofer M., Wenzler-Röttele S., Babikir R., Bertz H., Ebner W., Meyer E., Rüden H., Gastmeier P., Daschner F.D., Hospital Infection Surveillance System for Patients with Hematologic/Oncologic Malignancies Study Group Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project. Clin Infect Dis. 2005;40:926–931. doi: 10.1086/428046. [DOI] [PubMed] [Google Scholar]
  • 31.Blázquez R.M., Espinosa F.J., Martínez-Toldos C.M., Alemany L., García-Orenes M.C., Segovia M. Sensitivity of urinary antigen test in relation to clinical severity in a large outbreak of Legionella pneumonia in Spain. Eur J Clin Microbiol Infect Dis. 2005;24:488–491. doi: 10.1007/s10096-005-1361-3. [DOI] [PubMed] [Google Scholar]
  • 32.Domínguez J., Galí N., Matas L., Pedroso P., Hernández A., Padilla E., Ausina V. Evaluation of a rapid immunochromatographic assay for the detection of Legionella antigen in urine samples. Eur J Clin Microbiol Infect Dis. 1999;18:896–898. doi: 10.1007/s100960050427. [DOI] [PubMed] [Google Scholar]
  • 33.Waterer G.W., Baselski V.S., Wunderink R.G. Legionella and community-acquired pneumonia: a review of current diagnostic tests from a clinician's viewpoint. Am J Med. 2001;110:41–48. doi: 10.1016/s0002-9343(00)00624-0. [DOI] [PubMed] [Google Scholar]
  • 34.Deforges L., Legrand P., Tankovic J., Brun-Buisson C., Lang P., Soussy C.J. Case of false-positive results of the urinary antigen test for Legionella pneumophila. Clin Infect Dis. 1999;29:953–954. doi: 10.1086/520479. [DOI] [PubMed] [Google Scholar]
  • 35.Mykietiuk A., Carratalà J., Fernández-Sabé N., Dorca J., Verdaguer R., Manresa F., Gudiol F. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clin Infect Dis. 2005;40:794–799. doi: 10.1086/428059. [DOI] [PubMed] [Google Scholar]
  • 36.Domínguez J.A., Galí N., Pedroso P., Fargas A., Padilla E., Manterola J.M., Matas L. Comparison of the Binax Legionella urinary antigen enzyme immunoassay (EIA) with the Biotest Legionella Urin antigen EIA for detection of Legionella antigen in both concentrated and nonconcentrated urine samples. J Clin Microbiol. 1998;36:2718–2722. doi: 10.1128/jcm.36.9.2718-2722.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wever P.C., Yzerman E.P., Kuijper E.J., Speelman P., Dankert J. Rapid diagnosis of Legionnaires’ disease using an immunochromatographic assay for Legionella pneumophila serogroup 1 antigen in urine during an outbreak in the Netherlands. J Clin Microbiol. 2000;38:2738–2739. doi: 10.1128/jcm.38.7.2738-2739.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Yzerman E.P., den Boer J.W., Lettinga K.D., Schellekens J., Dankert J., Peeters M. Sensitivity of three urinary antigen tests associated with clinical severity in a large outbreak of Legionnaires’ disease in The Netherlands. J Clin Microbiol. 2002;40:3232–3236. doi: 10.1128/JCM.40.9.3232-3236.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Helbig J.H., Uldum S.A., Bernander S., Lück P.C., Wewalka G., Abraham B., Gaia V., Harrison T.G. Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires’ disease. J Clin Microbiol. 2003;41:838–840. doi: 10.1128/JCM.41.2.838-840.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Benson R.F., Tang P.W., Fields B.S. Evaluation of the Binax and Biotest urinary antigen kits for detection of Legionnaires’ disease due to multiple serogroups and species of Legionella. J Clin Microbiol. 2000;38:2763–2765. doi: 10.1128/jcm.38.7.2763-2765.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Den Boer J.W., Yzerman E.P. Diagnosis of Legionella infection in Legionnaires’ disease. Eur J Clin Microbiol Infect Dis. 2004;23:871–878. doi: 10.1007/s10096-004-1248-8. [DOI] [PubMed] [Google Scholar]
  • 42.Smith M.D., Derrington P., Evans R., Creek M., Morris R., Dance D.A., Cartwright K. Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation. J Clin Microbiol. 2003;41:2810–2813. doi: 10.1128/JCM.41.7.2810-2813.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Murdoch D.R. Nucleic acid amplification tests for the diagnosis of pneumonia. Clin Infect Dis. 2003;36:1162–1170. doi: 10.1086/374559. [DOI] [PubMed] [Google Scholar]
  • 44.Domínguez J., Galí N., Blanco S., Pedroso P., Prat C., Matas L., Ausina V. Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. Chest. 2001;119:243–249. doi: 10.1378/chest.119.1.243. [DOI] [PubMed] [Google Scholar]
  • 45.Murdoch D.R., Laing R.T., Mills G.D., Karalus N.C., Town G.I., Mirrett S., Reller L.B. Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. J Clin Microbiol. 2001;39:3495–3498. doi: 10.1128/JCM.39.10.3495-3498.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Jacobs E., Bennewitz A., Bredt W. Reaction pattern of human anti-Mycoplasma pneumoniae antibodies in enzyme-linked immunosorbent assays and immunoblotting. J Clin Microbiol. 1986;23:517–522. doi: 10.1128/jcm.23.3.517-522.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Abele-Horn M., Busch U., Nitschko H., Jacobs E., Bax R., Pfaff F., Schaffer B., Heesemann J. Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae. J Clin Microbiol. 1998;36:548–551. doi: 10.1128/jcm.36.2.548-551.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Dorigo-Zetsma J.W., Verkooyen R.P., van Helden H.P., van der Nat H., van den Bosch J.M. Molecular detection of Mycoplasma pneumoniae in adults with community-acquired pneumonia requiring hospitalization. J Clin Microbiol. 2001;39:1184–1186. doi: 10.1128/JCM.39.3.1184-1186.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Murdoch D.R. Impact of rapid microbiological testing on the management of lower respiratory tract infection. Clin Infect Dis. 2005;41:1445–1447. doi: 10.1086/497145. [DOI] [PubMed] [Google Scholar]
  • 50.van Elden L.J., van Kraaij M.G., Nijhuis M., Hendriksen K.A., Dekker A.W., Rozenberg-Arska M., van Loon A.M. Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia. Clin Infect Dis. 2002;34:177–183. doi: 10.1086/338238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Templeton K.E., Scheltinga S.A., van den Eeden W.C., Graffelman A.W., van den Broek P.J., Claas E.C. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–351. doi: 10.1086/431588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.van Elden L.J., van Loon A.M., van der Beek A., Hendriksen K.A., Hoepelman A.I., van Kraaij M.G., Schipper P., Nijhuis M. Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults. J Clin Microbiol. 2003;41:4378–4381. doi: 10.1128/JCM.41.9.4378-4381.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.van Elden L.J., van Loon A.M., van Alphen F., Hendriksen K.A., Hoepelman A.I., van Kraaij M.G., Oosterheert J.J., Schipper P., Schuurman R., Nijhuis M. Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel realtime reverse-transcriptase polymerase chain reaction. J Infect Dis. 2004;189:652–657. doi: 10.1086/381207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.van Kraaij M.G., van Elden L.J., van Loon A.M., Hendriksen K.A., Laterveer L., Dekker A.W., Nijhuis M. Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture. Clin Infect Dis. 2005;40:662–669. doi: 10.1086/427801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Martino R., Rámila E., Rabella N., Muñoz J.M., Peyret M., Portos J.M., Laborda R., Sierra J. Respiratory virus infections in adults with hematologic malignancies: a prospective study. Clin Infect Dis. 2003;36:1–8. doi: 10.1086/344899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Tanaka Y., Kanda Y., Kami M., Mori S., Hamaki T., Kusumi E., Miyakoshi S., Nannya Y., Chiba S., Arai Y., Mitani K., Hirai H., Mutou Y., Japan Hematology and Oncology Clinical Study Group (J-HOCS) Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;30:315–319. doi: 10.1038/sj.bmt.1703661. [DOI] [PubMed] [Google Scholar]
  • 57.Taplitz R.A., Jordan M.C. Pneumonia caused by herpesviruses in recipients of hematopoietic cell transplants. Semin Respir Infect. 2002;17:121–129. doi: 10.1053/srin.2002.33447. [DOI] [PubMed] [Google Scholar]
  • 58.Druce J., Catton M., Chibo D., Minerds K., Tyssen D., Kostecki R., Maskill B., Leong-Shaw W., Gerrard M., Birch C. Utility of a multiplex PCR assay for detecting herpesvirus DNA in clinical samples. J Clin Microbiol. 2002;40:1728–1732. doi: 10.1128/JCM.40.5.1728-1732.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Thomas C.F., Jr., Limper A.H. Pneumocystis pneumonia. N Engl J Med. 2004;350:2487–2498. doi: 10.1056/NEJMra032588. [DOI] [PubMed] [Google Scholar]
  • 60.Wakefield A.E., Guiver L., Miller R.F., Hopkin J.M. DNA amplification on induced sputum samples for diagnosis of Pneumocystis carinii pneumonia. Lancet. 1991;337:1378–1379. doi: 10.1016/0140-6736(91)93062-e. [DOI] [PubMed] [Google Scholar]
  • 61.Kovacs J.A., Hiemenz J.W., Macher A.M., Stover D., Murray H.W., Shelhamer J., Lane H.C., Urmacher C., Honig C., Longo D.L. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med. 1984;100:663–671. doi: 10.7326/0003-4819-100-5-663. [DOI] [PubMed] [Google Scholar]
  • 62.Arcenas R.C., Uhl J.R., Buckwalter S.P., Limper A.H., Crino D., Roberts G.D., Wengenack N.L. A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluid. Diagn Microbiol Infect Dis. 2006;54:169–175. doi: 10.1016/j.diagmicrobio.2005.08.006. [DOI] [PubMed] [Google Scholar]
  • 63.Durand-Joly I., Chabé M., Soula F., Delhaes L., Camus D., Dei-Cas E. Molecular diagnosis of Pneumocystis pneumonia. FEMS Immunol Med Microbiol. 2005;45:405–410. doi: 10.1016/j.femsim.2005.06.006. [DOI] [PubMed] [Google Scholar]
  • 64.Alvarez-Martínez M.J., Miró J.M., Valls M.E., Moreno A., Rivas P.V., Solé M., Benito N., Domingo P., Muñoz C., Rivera E., Zar H.J., Wissmann G., Diehl A.R., Prolla J.C., de Anta M.T., Gatell J.M., Wilson P.E., Meshnick S.R., Spanish PCP Working Group Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens. Diagn Microbiol Infect Dis. 2006;56:153–160. doi: 10.1016/j.diagmicrobio.2006.03.010. [DOI] [PubMed] [Google Scholar]
  • 65.Kovacs J.A., Gill V.J., Meshnick S., Masur H. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. Jama. 2001;286:2450–2460. doi: 10.1001/jama.286.19.2450. [DOI] [PubMed] [Google Scholar]
  • 66.Fischer S., Gill V.J., Kovacs J., Miele P., Keary J., Silcott V., Huang S., Borio L., Stock F., Fahle G., Brown D., Hahn B., Townley E., Lucey D., Masur H. The use of oral washes to diagnose Pneumocystis carinii pneumonia: a blinded prospective study using a polymerase chain reactionbased detection system. J Infect Dis. 2001;184:1485–1488. doi: 10.1086/324520. [DOI] [PubMed] [Google Scholar]
  • 67.Azoulay E., Bergeron A., Chevret S., Bele N., Schlemmer B., Menotti J. Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest. 2009;135:655–661. doi: 10.1378/chest.08-1309. [DOI] [PubMed] [Google Scholar]
  • 68.Ribes J.A., Limper A.H., Espy M.J., Smith T.F. PCR detection of Pneumocystis carinii in bronchoalveolar lavage specimens: analysis of sensitivity and specificity. J Clin Microbiol. 1997;35:830–835. doi: 10.1128/jcm.35.4.830-835.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Maertens J., Verhaegen J., Demuynck H., Brock P., Verhoef G., Vandenberghe P., Van Eldere J., Verbist L., Boogaerts M. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol. 1999;37:3223–3228. doi: 10.1128/jcm.37.10.3223-3228.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Ascioglu S., Rex J.H., de Pauw B., Bennett J.E., Bille J., Crokaert F., Denning D.W., Donnelly J.P., Edwards J.E., Erjavec Z., Fiere D., Lortholary O., Maertens J., Meis J.F., Patterson T.F., Ritter J., Selleslag D., Shah P.M., Stevens D.A., Walsh T.J., Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7–14. doi: 10.1086/323335. [DOI] [PubMed] [Google Scholar]
  • 71.Maertens J., Verhaegen J., Lagrou K., Van Eldere J., Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood. 2001;97:1604–1610. doi: 10.1182/blood.v97.6.1604. [DOI] [PubMed] [Google Scholar]
  • 72.Maertens J., Van Eldere J., Verhaegen J., Verbeken E., Verschakelen J., Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis. 2002;186:1297–1306. doi: 10.1086/343804. [DOI] [PubMed] [Google Scholar]
  • 73.Maertens J., Theunissen K., Verhoef G., Verschakelen J., Lagrou K., Verbeken E., Wilmer A., Verhaegen J., Boogaerts M., Van Eldere J. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis. 2005;41:1242–1250. doi: 10.1086/496927. [DOI] [PubMed] [Google Scholar]
  • 74.Borlenghi E., Cattaneo C., Capucci M.A., Pan A., Quaresmini G., Franco F., Grazioli L., Carosi G.P., Rossi G. Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates. Ann Hematol. 2007;86:205–210. doi: 10.1007/s00277-006-0204-3. [DOI] [PubMed] [Google Scholar]
  • 75.Subirà M., Martino R., Rovira M., Vazquez L., Serrano D., De La Cámara R. Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol. 2003;82:80–82. doi: 10.1007/s00277-002-0599-4. [DOI] [PubMed] [Google Scholar]
  • 76.Bretagne S., Marmorat-Khuong A., Kuentz M., Latgé J.P., Bart-Delabesse E., Cordonnier C. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J Infect. 1997;35:7–15. doi: 10.1016/s0163-4453(97)90833-1. [DOI] [PubMed] [Google Scholar]
  • 77.Hohenthal U., Itälä M., Salonen J., Sipilä J., Rantakokko-Jalava K., Meur man O., Nikoskelainen J., Vainionpää R., Kotilainen P. Bronchoalveolar lavage in immunocompromised patients with haematological malignancy-value of new microbiological methods. Eur J Haematol. 2005;74:203–211. doi: 10.1111/j.1600-0609.2004.00373.x. [DOI] [PubMed] [Google Scholar]
  • 78.Musher B., Fredricks D., Leisenring W., Balajee S.A., Smith C., Marr K.A. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol. 2004;42:5517–5522. doi: 10.1128/JCM.42.12.5517-5522.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Francesconi A., Kasai M., Petraitiene R., Petraitis V., Kalahar A.M., Schaufele R., Hope W.W., Shea Y.R., Bacher J., Walsh T.J. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J Clin Microbiol. 2006;44:2475–2480. doi: 10.1128/JCM.02693-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.MacArthur R.D., Miller M., Albertson T., Panack E., Johnson D., Teoh L., Barchak W. Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial. Clin Infect Dis. 2004;38:284–288. doi: 10.1086/379825. [DOI] [PubMed] [Google Scholar]
  • 81.Xu J., Moore J.E., Miller B.C., Alexander H.D., Maclarg R., Morris Tc, Rooney P.J. Improved laboratory diagnosis of bacterial and fungal infections in patients with hematological malignancies using PCR and ribosomal RNA sequence analysis. Leuk Lymphoma. 2004;45:1637–1641. doi: 10.1080/10428190410001667695. [DOI] [PubMed] [Google Scholar]
  • 82.Peters R.P., Van Agtmael M.A., Danner S.A., Savelkoul P.H., Vandenbroucke-Grauls C.M. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis. 2004;4:751–760. doi: 10.1016/S1473-3099(04)01205-8. [DOI] [PubMed] [Google Scholar]
  • 83.Louie R.F., Tang Z., Albertson T.E., Cohen S., Tran N.K., Kost G.J. Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia. Crit Care Med. 2008;36:1487–1492. doi: 10.1097/CCM.0b013e31816f487c. [DOI] [PubMed] [Google Scholar]
  • 84.Bloos F., Hinder F., Becker K., Sachse S., Dessap A.M., Straube E., Cattoir V., Brun-Buisson C., Reinhart K., Peters G., Bauer M. A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Med. 2010;36:241–247. doi: 10.1007/s00134-009-1705-z. [DOI] [PubMed] [Google Scholar]
  • 85.Skovbjerg S., Welinder-Olsson C., Kondori N., Kjellin E., Nowrouzian F., Wold A.E., Stockelberg D., Larsson P., Wenneras C. Optimization of the detection of microbes in blood from immunocompromised patients with haematological malignancies. Clin Microbiol Infect. 2009;15:680–683. doi: 10.1111/j.1469-0691.2009.02796.x. [DOI] [PubMed] [Google Scholar]
  • 86.Mancini N., Clerici D., Diotti R., Perotti M., Ghidoli N., De Marco D., Pizzorno B., Emrich T., Burioni R., Ciceri F., Clementi M. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. J Med Microbiol. 2008;57:601–604. doi: 10.1099/jmm.0.47732-0. [DOI] [PubMed] [Google Scholar]
  • 87.Perkins G.D., Chatterjee S., Giles S., McAuley D.F., Quinton S., Thickett D.R., Gao F. Safety and Tolerability of Nonbronchoscopic Lavage in ARDS. Chest. 2005;127:1358–1363. doi: 10.1378/chest.127.4.1358. [DOI] [PubMed] [Google Scholar]
  • 88.Sharma S., Nadrous H.F., Peters S.G., Tefferi A., Litzow M.R., Aubry M.C., Afessa B. Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings. Chest. 2005;128:1385–1392. doi: 10.1378/chest.128.3.1385. [DOI] [PubMed] [Google Scholar]

Articles from Revue Des Maladies Respiratoires Actualites are provided here courtesy of Elsevier

RESOURCES